These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15704683)

  • 101. Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats.
    An J; Kong H
    PLoS One; 2022; 17(5):e0268695. PubMed ID: 35584179
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [State of the gastric mucosa in patients with benign prostatic hyperplasia in the early postoperative period at initial stages of chronic renal failure].
    Aboian IA; Khanamirova LZ; Mitusov VV; Bubnova VI
    Urologiia; 2003; (4):22-5. PubMed ID: 12942721
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Prostatic hypertrophy].
    Lutzeyer W
    Z Allgemeinmed; 1971 Mar; 47(7):328-33. PubMed ID: 4104333
    [No Abstract]   [Full Text] [Related]  

  • 104. [Hormone treatment of benign prostatic hypertrophy].
    Sember M; Bernstein-Hahn L
    Rev Argent Urol Nefrol; 1969 Sep; 38(9):160-1. PubMed ID: 4190461
    [No Abstract]   [Full Text] [Related]  

  • 105. [On the action of an anabolic steroid on the blood protein pattern of prostatectomized patients].
    Bellanca Campo F; Motta M
    Arch Ital Urol Nefrol; 1967; 39(6):500-8. PubMed ID: 4179628
    [No Abstract]   [Full Text] [Related]  

  • 106. [Developments in the therapy of 2 typical diseases of aging males].
    Noszkay A
    Orv Hetil; 1973 Apr; 114(17):971-6. PubMed ID: 4121397
    [No Abstract]   [Full Text] [Related]  

  • 107. [Prostatic hyperplasia: conservative treatment].
    Bartsch G
    Urologe A; 1989 Nov; 28(6):305. PubMed ID: 2481354
    [No Abstract]   [Full Text] [Related]  

  • 108. Endocrinology of sexual dysfunction.
    Pirke KM; Kockott G
    Clin Endocrinol Metab; 1982 Nov; 11(3):625-37. PubMed ID: 7139992
    [No Abstract]   [Full Text] [Related]  

  • 109. [Indications and contraindications for prostatectomy].
    Enfedzhiev M
    Khirurgiia (Sofiia); 1972; 25(4):399-403. PubMed ID: 4119659
    [No Abstract]   [Full Text] [Related]  

  • 110. [Effect of treatment with mepartricin on the plasma androgen and gonadotropin concentrations in subjects with benign prostatic hypertrophy].
    Sciarra F; Bianchi P; Toscano V
    Minerva Urol Nefrol; 1988; 40(2 Suppl):10-2. PubMed ID: 2460936
    [No Abstract]   [Full Text] [Related]  

  • 111. [Comparative evaluation of quality of life of patients after surgery for benign prostatic hyperplasia].
    Loran OB; Esipov AV; Svistunov SP; Kernitskiĭ AI; Demkin VV; Lazarev AB
    Voen Med Zh; 2001 Apr; 322(4):43-8. PubMed ID: 11547666
    [No Abstract]   [Full Text] [Related]  

  • 112. [Considerations on the indications and prognosis of the prostatectomy operation in heart disease patients].
    Battenti F; Rossi G
    Arch Ital Urol Nefrol; 1967 Mar; 39(3):216-30. PubMed ID: 4177314
    [No Abstract]   [Full Text] [Related]  

  • 113. [Serum testosterone level and excretion of androgen metabolites in patients with hypertrophy of the prostatic gland].
    Baranowska B; Migdalska B; Szymanowski J; Kozlowicz I
    Endokrynol Pol; 1977; 28(1):45-52. PubMed ID: 64356
    [No Abstract]   [Full Text] [Related]  

  • 114. Pills for the benign prostate. Trial designs.
    Castro JE
    Proc R Soc Med; 1972 Feb; 65(2):126-7. PubMed ID: 4117435
    [No Abstract]   [Full Text] [Related]  

  • 115. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature.
    Neuhouser ML; Kristal AR; Penson DF
    Urology; 2004 Aug; 64(2):201-11. PubMed ID: 15302461
    [No Abstract]   [Full Text] [Related]  

  • 116. Benign prostatic hyperplasia.
    Kaplan SA; Koo HP
    Compr Ther; 1993; 19(1):21-4. PubMed ID: 7687530
    [No Abstract]   [Full Text] [Related]  

  • 117. [Conservative treatment of prostatic adenoma].
    Gikov D; Bozhilov I
    Khirurgiia (Sofiia); 1974; 27(5):398-403. PubMed ID: 4143140
    [No Abstract]   [Full Text] [Related]  

  • 118. [Dynamics of the indices of variation pulsimetry in prostatic adenoma patients].
    Guseĭnov KhS
    Urol Nefrol (Mosk); 1985; (2):26-8. PubMed ID: 2581351
    [No Abstract]   [Full Text] [Related]  

  • 119. [Gas gangrene after transvesical adenectomy. Case report].
    Ameur A; Jira H; Draoui D
    Ann Urol (Paris); 1999; 33(4):256-8. PubMed ID: 10510706
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Quality improvement activities in prostatectomy for benign prostatic hypertrophy.
    Eldar R
    Croat Med J; 2003 Apr; 44(2):244-5. PubMed ID: 12698520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.